Chimerix (CMRX) Appoints Marc D. Kozin to its Board
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/25/2026
- Nasdaq, S&P end lower as tech stocks fall
- Micron posts record profit as AI memory demand fuels explosive growth
- Brent settles at lowest since before start of Iran war as more tankers exit Hormuz
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
Chimerix Appoints Marc D. Kozin to Board of Directors
March 21, 2024 7:00 AM EDTDURHAM, N.C., March 21, 2024 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ: CMRX), a biopharmaceutical company whose mission is to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases, today announced the appointment of Marc D. Kozin as the newest member of the Companys Board of Directors. In addition, Patrick Machado has announced his retirement from the Chimerix Board effective at the Companys 2024 Annual Meeting of Stockholders in June, after ten years of service.
We are pleased to welcome Marc to the Board of Directors. Marcs strategic insights and... More
